267 related articles for article (PubMed ID: 7589632)
1. Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosis.
Kiilholma P; Tuimala R; Kivinen S; Korhonen M; Hagman E
Fertil Steril; 1995 Nov; 64(5):903-8. PubMed ID: 7589632
[TBL] [Abstract][Full Text] [Related]
2. Long-term use of gonadotropin-releasing hormone analogs and hormone replacement therapy in the management of endometriosis: a randomized trial with a 6-year follow-up.
Pierce SJ; Gazvani MR; Farquharson RG
Fertil Steril; 2000 Nov; 74(5):964-8. PubMed ID: 11056241
[TBL] [Abstract][Full Text] [Related]
3. The treatment of severe premenstrual syndrome with goserelin with and without 'add-back' estrogen therapy: a placebo-controlled study.
Leather AT; Studd JW; Watson NR; Holland EF
Gynecol Endocrinol; 1999 Feb; 13(1):48-55. PubMed ID: 10368798
[TBL] [Abstract][Full Text] [Related]
4. Gonadotropin-releasing hormone analogue (goserelin) plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial.
Howell R; Edmonds DK; Dowsett M; Crook D; Lees B; Stevenson JC
Fertil Steril; 1995 Sep; 64(3):474-81. PubMed ID: 7641897
[TBL] [Abstract][Full Text] [Related]
5. Add-back therapy in the treatment of endometriosis: the European experience.
Edmonds DK
Br J Obstet Gynaecol; 1996 Oct; 103 Suppl 14():10-3. PubMed ID: 8916980
[TBL] [Abstract][Full Text] [Related]
6. Gonadotropin-releasing hormone agonist plus "add-back" hormone replacement therapy for treatment of endometriosis: a prospective, randomized, placebo-controlled, double-blind trial.
Franke HR; van de Weijer PH; Pennings TM; van der Mooren MJ
Fertil Steril; 2000 Sep; 74(3):534-9. PubMed ID: 10973651
[TBL] [Abstract][Full Text] [Related]
7. [Clinical efficacy and safety of gonadotropin releasing hormone agonist combined with estrogen-dydrogesteronea in treatment of endometriosis].
Long QQ; Zhang SF; Han Y; Chen H; Li XL; Hua KQ; Hu WG
Zhonghua Fu Chan Ke Za Zhi; 2010 Apr; 45(4):247-51. PubMed ID: 20646533
[TBL] [Abstract][Full Text] [Related]
8. Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up.
Surrey ES; Hornstein MD
Obstet Gynecol; 2002 May; 99(5 Pt 1):709-19. PubMed ID: 11978277
[TBL] [Abstract][Full Text] [Related]
9. Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis: the role of cyclic sodium etidronate and low-dose norethindrone "add-back" therapy.
Surrey ES; Voigt B; Fournet N; Judd HL
Fertil Steril; 1995 Apr; 63(4):747-55. PubMed ID: 7890057
[TBL] [Abstract][Full Text] [Related]
10. Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis: A Randomized Controlled Trial.
DiVasta AD; Feldman HA; Sadler Gallagher J; Stokes NA; Laufer MR; Hornstein MD; Gordon CM
Obstet Gynecol; 2015 Sep; 126(3):617-627. PubMed ID: 26181088
[TBL] [Abstract][Full Text] [Related]
11. Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study. Lupron Add-Back Study Group.
Hornstein MD; Surrey ES; Weisberg GW; Casino LA
Obstet Gynecol; 1998 Jan; 91(1):16-24. PubMed ID: 9464714
[TBL] [Abstract][Full Text] [Related]
12. [Clinical study on the effectiveness and safety of combined laparoscopy and gonadotropin-releasing hormone agonist in the treatment of endometriosis].
Song JH; Lu H; Zhang J; Li B
Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):584-8. PubMed ID: 24199923
[TBL] [Abstract][Full Text] [Related]
13. Medroxyprogesterone acetate supplementation diminishes the hypoestrogenic side effects of gonadotropin-releasing hormone agonist without changing its efficacy in endometriosis.
Mäkäräinen L; Rönnberg L; Kauppila A
Fertil Steril; 1996 Jan; 65(1):29-34. PubMed ID: 8557151
[TBL] [Abstract][Full Text] [Related]
14. Extending the treatment boundaries: Zoladex and add-back.
Schlaff WD
Int J Gynaecol Obstet; 1999 Feb; 64 Suppl 1():S25-31. PubMed ID: 10096462
[TBL] [Abstract][Full Text] [Related]
15. Prevention of bone loss and hypoestrogenic symptoms by estrogen and interrupted progestogen add-back in long-term GnRH-agonist down-regulated patients with endometriosis and premenstrual syndrome.
Mitwally MF; Gotlieb L; Casper RF
Menopause; 2002; 9(4):236-41. PubMed ID: 12082359
[TBL] [Abstract][Full Text] [Related]
16. 17 beta-estradiol and norethisterone acetate in low doses as continuous combined hormone replacement therapy.
Stadberg E; Mattsson LA; Uvebrant M
Maturitas; 1996 Feb; 23(1):31-9. PubMed ID: 8861084
[TBL] [Abstract][Full Text] [Related]
17. The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy.
Sturdee DW; Ulrich LG; Barlow DH; Wells M; Campbell MJ; Vessey MP; Nielsen B; Anderson MC; Bragg AJ
BJOG; 2000 Nov; 107(11):1392-400. PubMed ID: 11117768
[TBL] [Abstract][Full Text] [Related]
18. A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis.
Vercellini P; Trespidi L; Colombo A; Vendola N; Marchini M; Crosignani PG
Fertil Steril; 1993 Jul; 60(1):75-9. PubMed ID: 8513962
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Adherence, Persistence, and Surgery Among Endometriosis Patients Treated with Leuprolide Acetate Plus Norethindrone Acetate Add-Back Therapy.
Soliman AM; Bonafede M; Farr AM; Castelli-Haley J; Winkel C
J Manag Care Spec Pharm; 2016 May; 22(5):573-87. PubMed ID: 27123918
[TBL] [Abstract][Full Text] [Related]
20. Goserelin acetate (Zoladex) with or without hormone replacement therapy for the treatment of endometriosis.
Moghissi KS; Schlaff WD; Olive DL; Skinner MA; Yin H
Fertil Steril; 1998 Jun; 69(6):1056-62. PubMed ID: 9627292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
